Showing results (61-70 of 3,787) with videos related to
Sort By:
Pageof 379
Oncoimmunology|July 4, 2015
Deficient regulatory B cells in human chronic graft-versus-host diseaseAdèle de Masson, Gérard Socié, Martine Bagot, et al.Oncoimmunology|July 4, 2015
Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transferJeannette Cany, Anniek B van der Waart, Jan Spanholtz, et al.Oncoimmunology|July 9, 2015
Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies-A reviewSandeep Nayar, Prokar Dasgupta, Christine GalustianOncoimmunology|July 9, 2015
The mutually regulatory loop of epithelial-mesenchymal transition and immunosuppression in cancer progressionLimo Chen, John V Heymach, F Xiao-Feng Qin, et al.Oncoimmunology|July 9, 2015
Akt1 and -2 inhibition diminishes terminal differentiation and enhances central memory CD8+ T-cell proliferation and survivalRasha Abu Eid, Kevin M Friedman, Mikayel Mkrtichyan, et al.Oncoimmunology|July 9, 2015
Trial watch: Naked and vectored DNA-based anticancer vaccinesNorma Bloy, Aitziber Buqué, Fernando Aranda, et al.Oncoimmunology|July 9, 2015
New role for antigen-presenting activated pDCs in promoting Th17 cells and impacting antitumor immunityLeslie Guéry, Stéphanie HuguesOncoimmunology|July 9, 2015
γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?Jaydeep Bhat, Dieter KabelitzOncoimmunology|July 9, 2015
Are BiTEs the "missing link" in cancer therapy?Carter M Suryadevara, Patrick C Gedeon, Luis Sanchez-Perez, et al.Oncoimmunology|July 9, 2015
Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survivalLaurent Muller, Sylvia Muller-Haegele, Masato Mitsuhashi, et al.Pageof 379